« Back to Record
Citation APA

Green, M. D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, R. I., Samonigg, H., Clemens, M., Zani, V., Liang, B. C., Renwick, J., Piccart-Gebhart, M., & International Pegfilgrastim 749 Study Group, (2003). A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Annals of oncology, 14(1), 29-35.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55262

Green, M. D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, R. I., Samonigg, H., Clemens, M., Zani, V., Liang, B. C., Renwick, J., Piccart-Gebhart, M., & International Pegfilgrastim 749 Study Group, (2003). A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Annals of oncology, 14(1), 29-35.